Alembic Pharmaceuticals LimitedNSE: APLLTD

Alembic Pharmaceuticals Limited Press Release Jun 26 2026

· Issued by Alembic Pharmaceuticals Limited via NSE India

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 26, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.".

View Attachment

Earlier from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases